Wall Street Beat
Danaher becomes dental giant with $2.1B Nobel Biocare buy
Second suitor ceded early to Zimmer in chase for Biomet
ReWalk Robotics prices IPO at $36M, below range
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
Mevion Medical files for $69M IPO
Kimberly-Clark readies Halyard Health medical device spinout
InVivo’s stock drops as ex-CEO dumps shares
As if InVivo Therapeutics (OTC:NVIV) wasn’t having a tough enough time already, the company’s stock is under even more pressure as former CEO Frank Reynolds has been liquidating his position over the last few weeks.